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in diab CHOP-10 KO compared to WT diab, 21 days after ischemia. 
This effect was associated with a reduction in the number of 
apoptotic cells and an increase in eNOS levels in diab CHOP-
10 KO compared to WT diab. We next analyzed the role of CHOP-
10 in post-natal vasculogenesis. Injection of BMC isolated from 
diab CHOP-10 KO in WT mice with hindlimb ischemia improved 
neovascularization by around 1.8-fold when compared to WT diab 
BMC (p<0.05). BMC isolated from diab CHOP-10 KO mice showed 
an upregulation of eNOS protein levels and an increase in their 
ability to differentiate into cells with endothelial phenotype in 
vitro differentiation assay. Finally, treatment of cultured HUVEC 
with homocysteine increased CHOP-10 mRNA levels and repressed 
eNOS gene expression. Consistent with these results, eNOS protein 
expression was signi cantly upregulated in the CHOP-10 siRNA—
transfected endothelial cells. Additionally, overexpression of 
CHOP-10 inhibited the basal transcriptional activation of the eNOS 
promoter as assessed by a reporter gene assay using a 3,500-bp 
fragment of the human eNOS gene.
Our study unravels an important inhibitory role of CHOP-10 in the 
regulation of vessel formation in the setting of diabetes.
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Hypoxia stimulates angiogenesis during development, as well as in 
the course of ischemic cardiovascular diseases and tumor growth. 
In a hypoxic environment, endothelial cells (EC) are key players 
of the angiogenic response. Their activation leads to remodeling 
of the extracellular matrix (ECM): a degradation step generates 
a provisional ECM supporting EC proliferation and migration ; 
assembly of a new basal lamina leads to pericyte recruitment and 
neovessel maturation.
In order to identify endothelial ECM proteins regulated by hypoxia, 
2D gel electrophoresis was performed on ECM samples prepared from 
cultured EC of micro or large vessels (HDMEC or HUVEC respectively). 
Mass spectrometry identi ed lysyl oxidase-like protein 2 (LOXL2) as a 
highly hypoxia-induced protein. Lysyl oxidases are secreted enzymes 
involved in ECM maturation through covalent cross-linking of its major 
components, collagens and elastin. The induction of LOXL2 expression 
was detected both at the mRNA and protein levels. Using siRNA, we 
demonstrated that LOXL2 is responsible for 65 % of lysyl oxidase total 
activity in hypoxic EC. In addition, LOXL2 protein was colocalised with 
type IV collagen in endothelial ECM.
We further investigated the expression of LOXL2 in vivo. The 
enzyme was expressed in rat EC from retina during postnatal 
vascular development, and from adult skeletal muscle. In a murine 
model of hindlimb ischemia, LOXL2 was upregulated at the protein 
and mRNA levels. In situ hybridization revealed its expression in 
both EC and macrophages.
Involvement of LOXL2 at different steps of the angiogenic process 
was further studied in vitro. We demonstrated that LOXL2 increases 
EC migration on  bronectin, as well as migration and tube formation 
in  brin 3D gels. In addition, LOXL2 knock-down inhibited type IV 
collagen deposition in the ECM, suggesting a major role for LOXL2 
in the organisation of endothelial basal lamina. Finally, whereas the 
ef ciency of endothelial ECM for recruiting VSMC was increased by 
hypoxia, this effect was reduced upon knocking down endothelial 
LOXL2 expression. Altogether, these data suggest that LOXL2 plays a 
major role in EC migration, vascular basal lamina deposition and neo-
vessel stabilisation during hypoxia-induced angiogenesis.
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Cell-based therapy is a promising option for treatment of 
cardiovascular diseases. Based on experimental studies 
demonstrating that bone marrow-derived mononuclear cells 
(BMMNCs) improve the functional recovery after ischemia, clinical 
trials were initiated to address this new therapeutic concept. 
BMMNCs improve neovascularization of ischemic tissue by a 
broad repertoire of potential therapeutic actions. Whereas initial 
studies documented that the cells incorporate and differentiate 
to cardiovascular cells, other studies suggested that short-time 
paracrine mechanisms mediate the bene cial effects. Here, we 
hypothesized that BMMNCs have a phagocytic ability, and switch 
to a proangiogenic phenotype after engulfment of apoptotic 
cells. Activation of such angiogenic program may be pivotal in 
the bene cial effect of BMMNCs-based therapy. In vitro, wild-
type (WT) BMMNCs ingestion of apoptotic cells upregulated the 
release of proangiogenic factors VEGF and HGF by 15- and 5-fold, 
respectively. In contrast, BMMNCs collected from mice de cient in 
MFG-E8, a protein that is required for attachment and engulfment 
of apoptotic cells by phagocytes, displayed lower phagocytic 
ability, leading to decrease in VEGF and HGF release. The capacity 
of BMMNCs to differentiate into cells with endothelial phenotype 
was similar in control and MFG-E8-de cient cells. In an in vivo 
model of mice myocardial infaction (MI), transplantation of WT 
BMMNCs increased fractionnal shortening (120 % of untreated 
control, p<0.05), 14 days after MI. Size of the infarct scar was 
reduced by 30 % (p<0.05 vs untreated control), and capillary density 
in the infarct border zone was raised by 10 % (p<0.05 vs untreated 
control) in the WT BMMNCs group. In contrast, transplantation 
of MFG-E8 de cient BMMNCs displayed no signi cant effect on 
cardiac function, infarct size or angiogenesis in the ischemic 
myocardium. Four days after MI, VEGF protein levels were raised 
by 1.4 fold in the myocardium of WT BMMNCs treated animals 
compared to untreated controls (p<0.05), while treatment with 
MFG-E8 de cient BMMNCs failed to raise VEGF levels. Taken 
together, these results suggest that phagocytosis of apoptotic 
cells reprograms BMMNCs into a proangiogenic phenotype. Hence, 
the therapeutic effect of transplanted BMMNCs depends, at least 
in part, on their phagocytic ability.
